Experts in multiple myeloma discuss highlights from the ASH 2023 meeting around transplant-eligible NDMM with particular focus on the PERSEUS and GRIFFIN trials and the clinical implications of the results of these studies.
Originally published by Māori Television Hawke’s Bay 11-year-old Perseus Ngapera (Ngāti Kahungunu, Ngāpuhi) is confident he will have lots of whānau support.